He is one of the most powerful people in the world, with an estimated fortune of 5,300 million euros. It is also one of the most hated people by all german soccer fans after going against the 50 + 1 rule. However, it may also be one of those that generates and distributes the coronavirus vaccine.
He is Dietmar Hopp, the main investor of the Hoffenheim, a team that until before the suspension of the championship was ranked ninth in the Bundesliga. In addition to owning the club, he also is in charge of financing the company CureVac, which as reported by the German portal "Dier Spiegel", is close to finding a possible cure for COVID-19.
Dietmar Hopp can go from being the most hated to being one of the heroes in the world-wide pandemic. Recently, the manager suffered a massive rejection led by the ultras of Borussia Dortmund and Bayern Munich, among others.
Dietmar Hopp earned the hatred of all German soccer fans after be against the 50 + 1 rule, a clause that is based on protecting the club from external shareholders, giving members the possibility to control the majority of votes (50 + 1) when making decisions.
Hopp, the largest shareholder of the German team He was the target of criticism and threats from different groups of ultras who chanted his name from the stands. "Hopp breaks his word, son of p …" was read in one of the flags displayed in the visiting sector of the match valid for the date 24 of the Bundesliga between Hoffenheim and Bayern Munich.
Now, Hopp could change the way of thinking of some fans after the local press reported that he is one of the largest shareholders in CureVac, a Tübingen-based biopharmaceutical company that He would be in the final stages when it comes to finding a cure for coronavirus.
A vaccine for which "Der Spiegel" came to reveal that Donald Trump, President of the United States, was interested in buying. Information that was denied by the German Federal Minister for the Economy, Peter Altmaier.
Subsequently, the New York Times stressed that Hopp was not interested in selling the possible cure since he wants the vaccine "not only to help the people of the region but also in solidarity throughout the world."
"We want to develop a vaccine to protect and help patients around the world and not for individual countries. We are very confident that we will be able to develop a potent vaccine in the coming months, ”the company said in a statement.